Geron | GERN - Pre Tax Profit

Stock Price
1.68
Daily Change
0.03 1.82%
Monthly
26.32%
Yearly
-4.55%
Q1 Forecast
1.82

Geron reported $-31.14M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
Bio Techne USD 84.99M 107.85M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Exelixis USD 252.69M 275K Dec/2025
Genmab DKK 482M 59M Sep/2025
Geron USD -31.14M 12.72M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Novavax USD -122.33M 286.92M Sep/2024